The Shape of Demand: What Does It Tell Us about Direct-to-Consumer Marketing of Antidepressants? : The B.E. Journal of Economic Analysis & Policy Jump to ContentJump to Main Navigation
Show Summary Details

The B.E. Journal of Economic Analysis & Policy

Editor-in-Chief: Jürges, Hendrik / Ludwig, Sandra

Ed. by Auriol , Emmanuelle / Brunner, Johann / Fleck, Robert / Mendola, Mariapia / Requate, Till / Zulehner, Christine / Schirle, Tammy


IMPACT FACTOR 2015: 0.250
5-year IMPACT FACTOR: 0.825

SCImago Journal Rank (SJR) 2015: 0.501
Source Normalized Impact per Paper (SNIP) 2015: 0.418
Impact per Publication (IPP) 2015: 0.455

Online
ISSN
1935-1682
See all formats and pricing

 


Select Volume and Issue
Loading journal volume and issue information...

The Shape of Demand: What Does It Tell Us about Direct-to-Consumer Marketing of Antidepressants?

Chad D. Meyerhoefer1 / Samuel H Zuvekas2

1Agency for Healthcare Research and Quality,

2Agency for Healthcare Research and Quality,

Citation Information: The B.E. Journal of Economic Analysis & Policy. Volume 8, Issue 2, ISSN (Online) 1935-1682, DOI: 10.2202/1935-1682.1805, January 2008

Publication History

Published Online:
2008-01-07

Abstract

Much of the debate surrounding Direct-to-Consumer Advertising (DTCA) of pharmaceuticals centers on whether DTCA conveys useful information to consumers or indiscriminately increases requests for the advertised medication. By identifying how DTCA changes the shape of the demand curve for antidepressants, we seek to infer the promotional objectives of manufacturers. Using data from the 1996-2003 Medical Expenditure Panel Survey (MEPS), we find that advertising shifts the demand curve for antidepressants outward and rotates it counter-clockwise. DTCA increases the probability that an individual will initiate use of antidepressants, particularly when out-of-pocket medication costs are low, but does not necessarily increase utilization levels among those already taking antidepressants. This is consistent with a promotional campaign that seeks to alert consumers to the product's existence, but conveys no real information that would allow them to learn their true match with the product.

Keywords: pharmaceutical demand; advertising; panel data

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Ciaran Driver
Journal of Economic Surveys, 2015, Page n/a
[2]
Marisa E. Domino
Health Economics, 2012, Volume 21, Number 4, Page 428
[3]
Chad D. Meyerhoefer, Samuel H. Zuvekas, and Richard Manski
Health Economics, 2014, Volume 23, Number 1, Page 14
[4]
Chad D. Meyerhoefer and Samuel H. Zuvekas
Health Economics, 2010, Volume 19, Number 3, Page 297

Comments (0)

Please log in or register to comment.